Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BALOXAVIR MARBOXIL Cause Intentional product use issue? 282 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 282 reports of Intentional product use issue have been filed in association with BALOXAVIR MARBOXIL (Xofluza). This represents 14.0% of all adverse event reports for BALOXAVIR MARBOXIL.

282
Reports of Intentional product use issue with BALOXAVIR MARBOXIL
14.0%
of all BALOXAVIR MARBOXIL reports
1
Deaths
1
Hospitalizations

How Dangerous Is Intentional product use issue From BALOXAVIR MARBOXIL?

Of the 282 reports, 1 (0.4%) resulted in death, 1 (0.4%) required hospitalization.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BALOXAVIR MARBOXIL. However, 282 reports have been filed with the FAERS database.

What Other Side Effects Does BALOXAVIR MARBOXIL Cause?

No adverse event (511) Off label use (409) Diarrhoea (120) Pneumonia (104) Vomiting (104) Drug ineffective (79) Nausea (64) Rash (55) Colitis ischaemic (54) Headache (54)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which BALOXAVIR MARBOXIL Alternatives Have Lower Intentional product use issue Risk?

BALOXAVIR MARBOXIL vs BALSALAZIDE BALOXAVIR MARBOXIL vs BAMLANIVIMAB BALOXAVIR MARBOXIL vs BAMLANIVIMAB\ETESEVIMAB BALOXAVIR MARBOXIL vs BARACLUDE BALOXAVIR MARBOXIL vs BARICITINIB

Related Pages

BALOXAVIR MARBOXIL Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue BALOXAVIR MARBOXIL Demographics